Tirzepatide: what it is and how it is sold in the US
Updated: 2026-10-29
Tirzepatide is a medication that acts on two hormone receptors (GIP and GLP-1). In the US it is sold under the brand names Zepbound and Mounjaro, which are FDA-approved, and some telehealth clinics offer compounded tirzepatide, which is not FDA-approved and is not the same as the brand. This page is information, not medical advice; we don't recommend doses.
Prices
See compounded tirzepatide price and brand GLP-1 prices.
FAQ
What is tirzepatide?
Tirzepatide is a medication that acts on GIP and GLP-1 receptors. The brand versions are Zepbound and Mounjaro. Talk to a licensed clinician about whether it fits you.
Is compounded tirzepatide the same as Zepbound?
No. Compounded tirzepatide is not FDA-approved and is not the same as the brand-name drug.
Related
Not medical advice. Compounded drugs are not FDA-approved and are not the same as brand-name drugs. Talk to a licensed clinician.